Canada faces a mounting public health crisis as alcohol-use disorder continues to cost the national healthcare system roughly $20 billion annually in medical, productivity, and criminal justice expenses, according to a national study published earlier this year in the Journal of Psychopharmacology. While Statistics Canada notes that overall consumption is ticking down slightly, those who do drink are consuming more. Research from the Centre for Addiction and Mental Health indicates that alcohol causes more overall harm in the country than non-prescription opioids or tobacco.
Hospitalizations and the Reality of Severe Alcohol Harm
The Canadian Institute for Health Information reports that nine people die in Canadian hospitals each day from alcohol-caused harm. Daily hospitalizations for alcohol reach 280, outpacing the 84 daily hospitalizations recorded for opioids. Nearly 18 per cent of people aged 15 and older in Canada meet the clinical criteria for an alcohol-use disorder during their lifetime.
Ailon notes that patients frequently encounter stigma in emergency rooms, where staff may dismiss them as chronic cases or advise them simply to cut back.
Underutilized Medical Treatments for High-Risk Drinking
Medical guidelines support specific pharmacological interventions for alcohol-use disorder, yet physicians rarely prescribe them. Naltrexone, approved by Health Canada in 1997, targets the brain’s opioid reward center to curb cravings and reduce relapse rates. Acamprosate, approved in 2007, stabilizes neurotransmitters disrupted by chronic alcohol use to help patients maintain abstinence.
Dr. Jürgen Rehm, a senior scientist at the Centre for Addiction and Mental Health and professor at the University of Toronto’s Dalla Lana School of Public Health, co-chaired a 2023 committee developing new guidelines for high-risk drinking. Rehm points out that the condition routinely goes unrecognized because neither physicians ask about alcohol habits nor patients volunteer the information early enough.
Alternative Approaches in In-Patient Care
For patients seeking residential support, options range from costly private facilities to community-led therapeutic models. Jordan Kawchuk, a 54-year-old writer and former TV producer, spent six months at the Vancouver Island Therapeutic Community in Nanaimo, B.C., marking his fifth in-patient program over decades of struggling with alcohol. Kawchuk lost his marriage and daily contact with his daughters before entering the free facility.
Chris Kinch, vice-president at the non-profit Connective which operates the Nanaimo facility, explains that their program relies on a structured schedule where residents build accountability through peer groups and social skills training. While some patients invest tens of thousands of dollars in private residential programs, Ailon cautions that returning to the exact same environment without addressing underlying drivers often leads back to relapse.
Did you know?
According to the Canadian Institute for Health Information, daily hospitalizations for alcohol-related harm stand at 280 across Canada, more than triple the daily hospitalizations recorded for opioids.
Frequently Asked Questions About Alcohol-Use Disorder Treatment
What medications are available for alcohol-use disorder in Canada?
Health Canada has approved medications such as Naltrexone, which reduces cravings by targeting the brain’s reward center, and Acamprosate, which helps maintain abstinence by balancing neurotransmitters affected by chronic use.
How common is alcohol-use disorder in Canada?
Nearly 18 per cent of Canadians aged 15 and older meet the clinical criteria for an alcohol-use disorder at some point in their lifetime, making it the country’s most pervasive drug problem.